|
Volumn 13, Issue 10, 2013, Pages 2773-2774
|
Successful treatment of chronic HCV infection should not preclude kidney donation to an HCV negative recipient
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PEGINTERFERON ALPHA;
RIBAVIRIN;
TACROLIMUS;
ADULT;
ANTIVIRAL THERAPY;
CASE REPORT;
ELASTOGRAPHY;
FEMALE;
FOLLOW UP;
GLOMERULUS FILTRATION RATE;
GRAFT RECIPIENT;
HEPATITIS C;
HUMAN;
HYPERTRANSAMINASEMIA;
IMMUNOGLOBULIN A NEPHROPATHY;
KIDNEY DONOR;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
LETTER;
LIVER SCINTISCANNING;
LIVING DONOR;
MALE;
NEPHRECTOMY;
PRIORITY JOURNAL;
RENAL REPLACEMENT THERAPY;
TREATMENT RESPONSE;
VIRUS LOAD;
FEMALE;
GLOMERULONEPHRITIS, IGA;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HUMANS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
PROGNOSIS;
TISSUE DONORS;
|
EID: 84884905850
PISSN: 16006135
EISSN: 16006143
Source Type: Journal
DOI: 10.1111/ajt.12400 Document Type: Letter |
Times cited : (20)
|
References (5)
|